|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Telmisartan#Overdosage]] |
| {{Telmisartan}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Overdosage==
| |
| | |
| Limited data are available with regard to overdosage in humans. The most likely manifestation of overdosage with MICARDIS tablets would be [[hypotension]], [[dizziness]] and [[tachycardia]]; [[bradycardia]] could occur from [[parasympathetic]] (vagal) stimulation. If symptomatic [[hypotension]] should occur, supportive treatment should be instituted. Telmisartan is not removed by [[hemodialysis]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MICARDIS (TELMISARTAN) TABLET [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cfb9309f-e0df-4a55-9542-0e869fce05fb | publisher = | date = | accessdate = 24 February 2014 }}</ref>
| |
| | |
| ==References==
| |
| {{reflist|2}}
| |
| | |
| {{Angiotensin II receptor antagonists}}
| |
| | |
| [[Category:Angiotensin II receptor antagonists]]
| |
| [[Category:Benzimidazoles]]
| |
| [[Category:Benzoic acids]]
| |
| [[Category:Biphenyls]]
| |
| [[Category:PPAR agonists]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |